U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 321

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr11:6636197-6636198
GRCh38:
Chr11:6614966-6614967
TPP1I484fsNeuronal ceroid lipofuscinosis 2Pathogeniccriteria provided, single submitter
2.
GRCh37:
Chr11:6640052-6640054
GRCh38:
Chr11:6618821-6618823
TPP1L61fsNeuronal ceroid lipofuscinosis 2Pathogeniccriteria provided, single submitter
3.
GRCh37:
Chr11:6636672-6636673
GRCh38:
Chr11:6615441-6615442
TPP1Neuronal ceroid lipofuscinosis 2Pathogeniccriteria provided, single submitter
4.
GRCh37:
Chr11:6635790
GRCh38:
Chr11:6614559
TPP1L560PNeuronal ceroid lipofuscinosis 2Uncertain significancecriteria provided, single submitter
5.
GRCh37:
Chr11:6639009
GRCh38:
Chr11:6617778
TPP1Neuronal ceroid lipofuscinosis 2Likely pathogenic
(May 2, 2023)
criteria provided, single submitter
6.
GRCh37:
Chr11:6637609
GRCh38:
Chr11:6616378
TPP1Q338ENeuronal ceroid lipofuscinosis 2Pathogenic
(Jun 24, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr11:6637276-6637277
GRCh38:
Chr11:6616045-6616046
TPP1S369fsNeuronal ceroid lipofuscinosis 2Likely pathogenic
(Jan 6, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr11:6637902
GRCh38:
Chr11:6616671
TPP1Y292*Neuronal ceroid lipofuscinosis 2Likely pathogenic
(Dec 30, 2021)
criteria provided, single submitter
9.
GRCh37:
Chr11:6638018
GRCh38:
Chr11:6616787
TPP1Q254*Neuronal ceroid lipofuscinosis 2Likely pathogenic
(Feb 19, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr11:6638011
GRCh38:
Chr11:6616780
TPP1S256*Neuronal ceroid lipofuscinosis 2Likely pathogenic
(Dec 17, 2021)
criteria provided, single submitter
11.
GRCh37:
Chr11:6638255
GRCh38:
Chr11:6617024
TPP1S213*Neuronal ceroid lipofuscinosis 2Likely pathogenic
(Dec 29, 2021)
criteria provided, single submitter
12.
GRCh37:
Chr11:6638255-6638257
GRCh38:
Chr11:6617024-6617026
TPP1S213fsNeuronal ceroid lipofuscinosis 2Likely pathogenic
(Dec 17, 2021)
criteria provided, single submitter
13.
GRCh37:
Chr11:6638998-6638999
GRCh38:
Chr11:6617767-6617768
TPP1L80fsNeuronal ceroid lipofuscinosis 2Likely pathogenic
(May 18, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr11:6637717
GRCh38:
Chr11:6616486
TPP1E302*Neuronal ceroid lipofuscinosis 2Likely pathogenic
(Mar 17, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr11:6636762-6636763
GRCh38:
Chr11:6615531-6615532
TPP1F393fsNeuronal ceroid lipofuscinosis 2Likely pathogenic
(Mar 17, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr11:6636739-6636740
GRCh38:
Chr11:6615508-6615509
TPP1T400fsNeuronal ceroid lipofuscinosis 2Likely pathogenic
(Mar 14, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr11:6638967-6638975
GRCh38:
Chr11:6617736-6617744
TPP1L88fsNeuronal ceroid lipofuscinosis 2Likely pathogenic
(Mar 3, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr11:6637600-6637601
GRCh38:
Chr11:6616369-6616370
TPP1N341fsNeuronal ceroid lipofuscinosis 2Likely pathogenic
(Mar 3, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr11:6640089
GRCh38:
Chr11:6618858
TPP1T50fsNeuronal ceroid lipofuscinosis 2Likely pathogenic
(Feb 20, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr11:6636689-6636691
GRCh38:
Chr11:6615458-6615460
TPP1P417fsNeuronal ceroid lipofuscinosis 2Likely pathogenic
(Feb 19, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr11:6636725-6636726
GRCh38:
Chr11:6615494-6615495
TPP1D405fsNeuronal ceroid lipofuscinosis 2Likely pathogenic
(Jan 27, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr11:6637609
GRCh38:
Chr11:6616378
TPP1Q338*Neuronal ceroid lipofuscinosis 2Likely pathogenic
(Apr 20, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr11:6636771
GRCh38:
Chr11:6615540
TPP1G390RNeuronal ceroid lipofuscinosis 2Uncertain significance
(Sep 1, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr11:6640106
GRCh38:
Chr11:6618875
TPP1E44*Neuronal ceroid lipofuscinosis 2Pathogenic
(Jun 9, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr11:6637722
GRCh38:
Chr11:6616491
TPP1G300fsNeuronal ceroid lipofuscinosis 2Pathogenic
(May 4, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr11:6636696
GRCh38:
Chr11:6615465
TPP1V415MAutosomal recessive spinocerebellar ataxia 7, Neuronal ceroid lipofuscinosis 2Uncertain significance
(Feb 8, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr11:6638390
GRCh38:
Chr11:6617159
TPP1Autosomal recessive spinocerebellar ataxia 7, Neuronal ceroid lipofuscinosis 2, not provided
Uncertain significance
(Apr 18, 2022)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr11:6636548
GRCh38:
Chr11:6615317
TPP1T427SAutosomal recessive spinocerebellar ataxia 7, Neuronal ceroid lipofuscinosis 2, not provided
Uncertain significance
(May 14, 2022)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr11:6637236
GRCh38:
Chr11:6616005
TPP1S382NAutosomal recessive spinocerebellar ataxia 7, Neuronal ceroid lipofuscinosis 2, not provided
Uncertain significance
(Jun 21, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr11:6637605
GRCh38:
Chr11:6616374
TPP1R339Lnot provided, Neuronal ceroid lipofuscinosis 2Conflicting interpretations of pathogenicity
(Jul 22, 2019)
criteria provided, conflicting interpretations
31.
GRCh37:
Chr11:6636300
GRCh38:
Chr11:6615069
TPP1Autosomal recessive spinocerebellar ataxia 7, not provided, Neuronal ceroid lipofuscinosis 2
Benign
(Jul 10, 2021)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr11:6635843
GRCh38:
Chr11:6614612
TPP1W542*Neuronal ceroid lipofuscinosis 2, not providedPathogenic
(Jan 16, 2023)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr11:6637632-6637634
GRCh38:
Chr11:6616401-6616403
TPP1E329delNeuronal ceroid lipofuscinosis 2Pathogenic
(Jan 30, 2020)
criteria provided, single submitter
34.
GRCh37:
Chr11:6637653
GRCh38:
Chr11:6616422
TPP1V323Anot providedUncertain significance
(Mar 26, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr11:6636153
GRCh38:
Chr11:6614922
TPP1P499Tnot providedUncertain significance
(Aug 21, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr11:6637723
GRCh38:
Chr11:6616492
TPP1G300Rnot providedUncertain significance
(Aug 31, 2021)
criteria provided, single submitter
37.
GRCh37:
Chr11:6636446
GRCh38:
Chr11:6615215
TPP1V461Lnot providedUncertain significance
(Oct 18, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr11:6637887
GRCh38:
Chr11:6616656
TPP1not providedUncertain significance
(Jan 7, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr11:6638300
GRCh38:
Chr11:6617069
TPP1L198Pnot providedUncertain significance
(Jul 6, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr11:6640437
GRCh38:
Chr11:6619206
TPP1Q27Enot providedUncertain significance
(Feb 9, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr11:6637976
GRCh38:
Chr11:6616745
TPP1R268Wnot providedUncertain significance
(Jun 23, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr11:6640440
GRCh38:
Chr11:6619209
TPP1D26Nnot providedUncertain significance
(Feb 8, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr11:6640428
GRCh38:
Chr11:6619197
TPP1T30Anot providedUncertain significance
(Aug 28, 2021)
criteria provided, single submitter
44.
GRCh37:
Chr11:6637629
GRCh38:
Chr11:6616398
TPP1S331Ynot providedUncertain significance
(Jul 3, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr11:6637975
GRCh38:
Chr11:6616744
TPP1R268Qnot providedUncertain significance
(Aug 8, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr11:6638027
GRCh38:
Chr11:6616796
TPP1F251Lnot provided, Neuronal ceroid lipofuscinosis 2Uncertain significance
(Oct 3, 2021)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr11:6638091
GRCh38:
Chr11:6616860
TPP1Neuronal ceroid lipofuscinosis 2Pathogenic
(Feb 4, 2020)
criteria provided, single submitter
48.
GRCh37:
Chr11:6636487
GRCh38:
Chr11:6615256
TPP1R447PNeuronal ceroid lipofuscinosis 2Likely pathogenic
(Feb 4, 2020)
criteria provided, single submitter
49.
GRCh37:
Chr11:6640505
GRCh38:
Chr11:6619274
TPP1Neuronal ceroid lipofuscinosis 2Uncertain significance
(Aug 13, 2020)
no assertion criteria provided
50.
GRCh37:
Chr11:6640503
GRCh38:
Chr11:6619272
TPP1Neuronal ceroid lipofuscinosis 2Uncertain significance
(Aug 17, 2020)
no assertion criteria provided
51.
GRCh37:
Chr11:6640481
GRCh38:
Chr11:6619250
TPP1A12VNeuronal ceroid lipofuscinosis 2Uncertain significance
(Apr 14, 2020)
no assertion criteria provided
52.
GRCh37:
Chr11:6640465
GRCh38:
Chr11:6619234
TPP1not providedLikely benign
(Oct 23, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr11:6638522
GRCh38:
Chr11:6617291
TPP1not providedLikely benign
(Aug 30, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr11:6638379
GRCh38:
Chr11:6617148
TPP1G172RNeuronal ceroid lipofuscinosis 2Uncertain significance
(Apr 14, 2020)
no assertion criteria provided
55.
GRCh37:
Chr11:6637971
GRCh38:
Chr11:6616740
TPP1not providedLikely benign
(Sep 24, 2022)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr11:6637291
GRCh38:
Chr11:6616060
TPP1G364Rnot providedUncertain significance
(Jul 30, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr11:6636214
GRCh38:
Chr11:6614983
TPP1not providedLikely benign
(Aug 24, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr11:6635899
GRCh38:
Chr11:6614668
TPP1E524KNeuronal ceroid lipofuscinosis 2Uncertain significance
(Apr 14, 2020)
no assertion criteria provided
59.
GRCh37:
Chr11:6637935
GRCh38:
Chr11:6616704
TPP1M281INeuronal ceroid lipofuscinosis 2Uncertain significance
(Jan 1, 2019)
criteria provided, single submitter
60.
GRCh37:
Chr11:6638360
GRCh38:
Chr11:6617129
TPP1P178fsNeuronal ceroid lipofuscinosis 2Likely pathogenic
(Oct 16, 2018)
criteria provided, single submitter
61.
GRCh37:
Chr11:6637541
GRCh38:
Chr11:6616310
TPP1not providedUncertain significance
(Sep 6, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr11:6636205
GRCh38:
Chr11:6614974
TPP1F481Lnot providedUncertain significance
(Jul 12, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr11:6637656
GRCh38:
Chr11:6616425
TPP1T322Inot providedUncertain significance
(Oct 13, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr11:6637732
GRCh38:
Chr11:6616501
TPP1R297Wnot provided, Neuronal ceroid lipofuscinosis 2Conflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
65.
GRCh37:
Chr11:6640621
GRCh38:
Chr11:6619390
TPP1Q4Lnot providedLikely benign
(Oct 13, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr11:6639015
GRCh38:
Chr11:6617784
TPP1not providedLikely benign
(Oct 15, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr11:6637544
GRCh38:
Chr11:6616313
TPP1not providedPathogenic
(Aug 15, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr11:6637587
GRCh38:
Chr11:6616356
TPP1M345Tnot providedUncertain significance
(Jun 9, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr11:6640149
GRCh38:
Chr11:6618918
TPP1not providedUncertain significance
(Aug 16, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr11:6638008
GRCh38:
Chr11:6616777
TPP1V257Anot providedUncertain significance
(Jun 22, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr11:6638392
GRCh38:
Chr11:6617161
TPP1not providedUncertain significance
(Aug 24, 2021)
criteria provided, single submitter
72.
GRCh37:
Chr11:6636669
GRCh38:
Chr11:6615438
TPP1not providedUncertain significance
(Sep 1, 2021)
criteria provided, single submitter
73.
GRCh37:
Chr11:6638943
GRCh38:
Chr11:6617712
TPP1not providedLikely benign
(Oct 17, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr11:6635806
GRCh38:
Chr11:6614575
TPP1A555Tnot providedUncertain significance
(Feb 4, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr11:6637618
GRCh38:
Chr11:6616387
TPP1A335Tnot provided, Inborn genetic diseasesUncertain significance
(Feb 4, 2022)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr11:6638358
GRCh38:
Chr11:6617127
TPP1T179Snot providedUncertain significance
(Aug 23, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr11:6634299
GRCh38:
Chr11:6613068
TPP1Neuronal ceroid lipofuscinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
78.
GRCh37:
Chr11:6634269
GRCh38:
Chr11:6613038
TPP1Neuronal ceroid lipofuscinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
79.
GRCh37:
Chr11:6634237
GRCh38:
Chr11:6613006
TPP1Neuronal ceroid lipofuscinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
80.
GRCh37:
Chr11:6634217
GRCh38:
Chr11:6612986
TPP1Neuronal ceroid lipofuscinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
81.
GRCh37:
Chr11:6635931
GRCh38:
Chr11:6614700
TPP1not provided, Neuronal ceroid lipofuscinosis 2Conflicting interpretations of pathogenicity
(Nov 1, 2021)
criteria provided, conflicting interpretations
82.
GRCh37:
Chr11:6635653
GRCh38:
Chr11:6614422
TPP1Neuronal ceroid lipofuscinosis 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
83.
GRCh37:
Chr11:6635606
GRCh38:
Chr11:6614375
TPP1Neuronal ceroid lipofuscinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
84.
GRCh37:
Chr11:6635554
GRCh38:
Chr11:6614323
TPP1Neuronal ceroid lipofuscinosis 2Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
85.
GRCh37:
Chr11:6634036
GRCh38:
Chr11:6612805
TPP1Neuronal ceroid lipofuscinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
86.
GRCh37:
Chr11:6635431
GRCh38:
Chr11:6614200
TPP1Neuronal ceroid lipofuscinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
87.
GRCh37:
Chr11:6635073
GRCh38:
Chr11:6613842
TPP1Neuronal ceroid lipofuscinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
88.
GRCh37:
Chr11:6635061
GRCh38:
Chr11:6613830
TPP1Neuronal ceroid lipofuscinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
89.
GRCh37:
Chr11:6634948
GRCh38:
Chr11:6613717
TPP1Neuronal ceroid lipofuscinosis 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
90.
GRCh37:
Chr11:6634840
GRCh38:
Chr11:6613609
TPP1Neuronal ceroid lipofuscinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
91.
GRCh37:
Chr11:6634793
GRCh38:
Chr11:6613562
TPP1Neuronal ceroid lipofuscinosis 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
92.
GRCh37:
Chr11:6635536
GRCh38:
Chr11:6614305
TPP1Neuronal ceroid lipofuscinosis 2Benign
(Apr 27, 2017)
criteria provided, single submitter
93.
GRCh37:
Chr11:6637628
GRCh38:
Chr11:6616397
TPP1Neuronal ceroid lipofuscinosis 2, not providedConflicting interpretations of pathogenicity
(Aug 9, 2022)
criteria provided, conflicting interpretations
94.
GRCh37:
Chr11:6634669
GRCh38:
Chr11:6613438
TPP1Neuronal ceroid lipofuscinosis 2Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
95.
GRCh37:
Chr11:6634527
GRCh38:
Chr11:6613296
TPP1Neuronal ceroid lipofuscinosis 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
96.
GRCh37:
Chr11:6634495
GRCh38:
Chr11:6613264
TPP1Neuronal ceroid lipofuscinosis 2Uncertain significance
(Jan 15, 2018)
criteria provided, single submitter
97.
GRCh37:
Chr11:6638914
GRCh38:
Chr11:6617683
TPP1A108Vnot providedConflicting interpretations of pathogenicity
(Sep 7, 2022)
criteria provided, conflicting interpretations
98.
GRCh37:
Chr11:6638559
GRCh38:
Chr11:6617328
TPP1Q161*not provided, Neuronal ceroid lipofuscinosis 2, Autosomal recessive spinocerebellar ataxia 7,
Neuronal ceroid lipofuscinosis
Pathogenic/Likely pathogenic
(Jul 22, 2022)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr11:6637552
GRCh38:
Chr11:6616321
TPP1A357Pnot providedUncertain significance
(Oct 9, 2021)
criteria provided, single submitter
100.
GRCh37:
Chr11:6638988
GRCh38:
Chr11:6617757
TPP1E83Dnot providedUncertain significance
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination